ALVO
AlvotechNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$1.04B
P/E Ratio
33.40
EPS
$0.10
Beta
0.21
52W High
$11.85
52W Low
$3.03
50-Day MA
$3.47
200-Day MA
$5.57
Dividend Yield
—
Profit Margin
-14.40%
Forward P/E
7.91
PEG Ratio
—
About Alvotech
Alvotech Holdings SA, develops and manufactures biosimilars for global markets. The company is headquartered in Iceland.
Fundamentals
| Revenue (TTM) | $562.04M |
| Gross Profit (TTM) | $345.85M |
| EBITDA | $105.10M |
| Operating Margin | 9.13% |
| Return on Equity | 0.00% |
| Return on Assets | 3.84% |
| Revenue/Share (TTM) | $1.80 |
| Book Value | $-0.91 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | 1.85 |
| EV/Revenue | 3.955 |
| EV/EBITDA | 7.46 |
| Quarterly Earnings Growth (YoY) | -99.10% |
| Quarterly Revenue Growth (YoY) | -20.20% |
| Shares Outstanding | $312.05M |
| Float | $114.09M |
| % Insiders | 62.75% |
| % Institutions | 6.48% |
Historical Volatility
HV 10-Day
69.97%
HV 20-Day
73.62%
HV 30-Day
64.15%
HV 60-Day
67.24%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($13.83 target)
1
Strong Buy3
Buy1
Hold1
Strong SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026